Venous thromboembolism in patients with pancreatic adenocarcinoma: Lower incidence in Asian ethnicity

Thrombosis Research

Volumn 122, Issue 4, 2008, Pages 485-490

  Oh, So Yeon ^a   Kim, Jee Hyun ^a   Lee, Keun Wook ^a   Bang, Soo Mee ^a   Hwang, Jin Hyeok ^a   Oh, Doyeun ^b   Lee, Jong Seok ^a  

^a Seoul National University Bundang Hospital   (South Korea)

^b CHA University   (South Korea)

Author keywords

Brain infarctions; Ethnic groups; Pancreatic cancer; Thromboembolism

Indexed keywords

ADULT; ADVANCED CANCER; AGED; ARTICLE; ASIAN; BRAIN INFARCTION; CANCER CHEMOTHERAPY; CANCER DIAGNOSIS; CANCER PATIENT; CANCER SURVIVAL; CONTROLLED STUDY; ETHNICITY; FEMALE; FOLLOW UP; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; MALE; MEDICAL ASSESSMENT; MEDICAL RECORD REVIEW; METASTASIS; MORBIDITY; PANCREAS ADENOCARCINOMA; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SURVIVAL TIME; TEACHING HOSPITAL; VENOUS THROMBOEMBOLISM;

ADENOCARCINOMA; ADULT; AGED; AGED, 80 AND OVER; ASIAN CONTINENTAL ANCESTRY GROUP; FEMALE; HUMANS; INCIDENCE; KOREA; MALE; MIDDLE AGED; NEOPLASM METASTASIS; PANCREATIC NEOPLASMS; RISK; VENOUS THROMBOEMBOLISM;

EID: 48049084145     PISSN: 00493848     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.thromres.2007.12.015     Document Type: Article

References (22)

1. Prandoni P., Falanga A., and Piccioli A. Cancer and venous thromboembolism. Lancet Oncol 6 (2005) 401-410
2. Sorensen H.T., Mellemkjaer L., Olsen J.H., and Baron J.A. Prognosis of cancers associated with venous thromboembolism. N Engl J Med 343 (2000) 1846-1850
3. Zacharski L.R. Anticoagulants in cancer treatment: malignancy as a solid phase coagulopathy. Cancer Lett 186 (2002) 1-9
4. Pross M., Lippert H., Misselwitz F., Nestler G., Kruger S., Langer H., et al. Low molecular weight heparin (reviparin) diminishes tumor cell adhesion and invasion in vitro, and decreases intraperitoneal growth of colon adenocarcinoma cells in rats after laparascopy. Thromb Res 110 (2003) 215-220
5. Kakkar A.K., Levine M.N., Kadziola Z., Lemoine N.R., Low V., Patel H.K., et al. Low molecular weight heparin, therapy with dalteparin, and survival in advanced cancer: the Fragmin Advanced Malignancy Outcome Study (FAMOUS). J Clin Oncol 22 (2004) 1944-1948
6. Voorthuizen T.V., Vervenne W.L., Van Daalen E.H., Phoa S.S., Gouma D.J., Bruno M.J., et al. A randomized phase II study comparing gemcitabine plus nadroparine versus gemcitabine in patients with locally advanced or metastatic pancreatic carcinoma: the GEMFRAX trial. J Clin Oncol 24 Suppl;abstr 4112 (2006) 18s
7. Levitan N., Dowlati A., Remick S.C., Tahsildar H.I., Sivinski L.D., Beyth R., et al. Rates of initial and recurrent thromboembolic disease among patients with malignancy versus those without malignancy. Risk analysis using Medicare claims data. Medicine (Baltimore) 78 (1999) 285-291
8. Thodiyil P.A., and Kakkar A.K. Variation in relative risk of venous thromboembolism in different cancers. Thromb Haemost 87 (2002) 1076-1077
9. Chew H.K., Wun T., Harvey D., Zhou H., and White R.H. Incidence of venous thromboembolism and its effect on survival among patients with common cancers. Arch Intern Med 166 (2006) 458-464
10. Khorana A.A., Francis C.W., Culakova E., Fisher R.I., Kuderer N.M., and Lyman G.H. Thromboembolism in hospitalized neutropenic cancer patients. J Clin Oncol 24 (2006) 484-490
11. Khorana A.A., Culakova E., Lyman G.H., and Francis C.W. Incidence of thromboembolic events in a prospective nationwide registry of cancer patients initiating systemic chemotherapy. J Clin Oncol 22 Suppl;abstr 8019 (2004) 14s
12. Blom J.W., Osanto S., and Rosendaal F.R. High risk of venous thrombosis in patients with pancreatic cancer: a cohort study of 202 patients. Eur J Cancer 42 (2006) 410-414
13. White R.H. The epidemiology of venous thromboembolism. Circulation 107 (2003) 14-18
14. White R.H., Zhou H., and Romano P.S. Incidence of idiopathic deep venous thrombosis and secondary thromboembolism among ethnic groups in California. Ann Intern Med 128 (1998) 737-740
15. Klatsky A.L., Armstrong M.A., and Poggi J. Risk of pulmonary embolism and/or deep venous thrombosis in Asian-Americans. Am J Cardiol 85 (2000) 1334-1337
16. Ridker P.M., Miletich J.P., Hennekens C.H., and Buring J.E. Ethnic distribution of factor V Leiden in 4047 men and women. Implications for venous thromboembolism screening. JAMA 277 (1997) 1305-1307
17. Gregg J.P., Yamane A.J., and Grody W.W. Prevalence of the factor V-Leiden mutation in four distinct American ethnic populations. Am J Med Genet 76 (1997) 334-336
18. Akkawat B., and Rojnuckarin P. Protein S deficiency is common in a healthy Thai population. J Med Assoc Thail 88 (2005) S249-S254
19. Shen M.C., Lin J.S., and Tsay W. High prevalence of antithrombin III, protein C and protein S deficiency, but no factor V Leiden mutation in venous thrombophilic Chinese patients in Taiwan. Thromb Res 87 (1997) 377-385
20. Shen M.C., Lin J.S., and Tsay W. Protein C and Protein S deficiencies are the most important risk factors associated with thrombosis in Chinese venous thrombophilic patients in Taiwan. Thromb Res 99 (2000) 447-452
21. Graus F., Rogers L.R., and Posner J.B. Cerebrovascular complications in patients with cancer. Medicine 64 (1985) 16-35
22. Rogers L.R. Cerebrovascular complications in cancer patients. Neurol Clin N Am 21 (2003) 167-192